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Abstract
Purpose We have developed iodine-supported titanium im-
plants that suppress microbial activities and conducted
in vivo and in vitro studies to determine their antimicrobial
properties.
Methods The implants were Ti-6Al-4 V titanium implants
either untreated (Ti), treated with oxide film on the Ti surface
by anodization (Ti-O), or treated with an iodine coating on
oxidation film (Ti-I). The strain of bacteria used in this study
was Gram-positive Staphylococcus aureus strain ATCC
25923. We analyzed the antibacterial attachment effects
in vivo by using rats. The attachment bacteria on the implant
surface were evaluated using a spread-plate method assay. A
biofilm study was performed in vitro. The biofilm formed
after bacterial attachment was qualitatively studied with fluo-
rescence microscopy (FM) and scanning electron microscopy
(SEM). Also, the formed biofilm was quantitatively studied
with a spread-plate method assay.
Results In vivo analysis of antimicrobial attachment effects
showed that the mean viable bacterial number was significant-
ly lower on Ti-I than Ti or Ti-O surfaces. In the in vitro biofilm
study, FM and SEM images showed thick and mature biofilm
formation on Ti and Ti-O and thin, small biofilm formation on
Ti-I. A quantitative biofilm analysis found a significant differ-
ence in the number of viable bacteria between Ti-I and Ti or
Ti-O.
Conclusions This study showed that iodine-supported im-
plants have a good antibacterial attachment effect and inhibit
biofilm formation and growth. Iodine-supported implants may
have great potential as innovative antibacterial implants that
can prevent implant related infection in orthopaedic surgery.
Keywords Iodine-supported implant . Implant related
infection . Biofilm . Antibacterial attachment effect
Introduction
In orthopaedic surgery, infection is one of the most common
and most challenging complications following implant place-
ment. Studies have shown that the postoperative infection rate
after total hip arthroplasty is 2.2%, while infection rate after
spinal surgery is 2.0% despite strict antiseptic procedures [1,
2]. Other studies show that almost 50% of patients experience
pin tract infection after pin insertion for external fixation [3,
4]. Once bacteria adhere to metal surfaces, they produce an
extracellular polymeric matrix instead of substance and form a
biofilm. The biofilm on the metal surface is resistant to almost
all antibiotics except rifampicin and protected from immune
surveillance. Such infections can be difficult to cure without
removing the medical devices, along with extensive bone or
soft tissue debridement.
On the premise that modification of the implant surface could
help prevent bacterial adhesion, a variety of biomaterials with
antimicrobial effects have been developed as implant surface
coatings including: either quaternary ammonium compounds,
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chitosan-nanoparticle loaded implants, phosphatidylcholine-
based material, and antibacterial loaded (vancomycin, etc.) im-
plants [5–13]. In particular, the usefulness of silver as an anti-
bacterial agent has been widely investigated because of its
strong broad-spectrum antibacterial properties [11]. Although
silver-coated implants definitely have good antibacterial effects,
the possibility of low biocompatibility and toxic effects on hu-
man cells cannot be ignored [14–16]. In an effort to develop a
biomaterial with both good antibacterial effects and low toxic
effects, we developed iodine-supported titanium implants that
suppress microbial activities. Shirai et al. demonstrated the an-
tibacterial attachment effect and cytocompatibility of iodine-
supported implants in an in vitro study [17]. However, no re-
ports to date have shown the antibacterial attachment effect of
iodine-supported implants in an in vivo study, nor has anyone
yet addressed the inhibition of biofilm formation and growth,
which is a clinically important factor.
In this study, the authors investigated the following ques-
tions: (1) Do iodine-supported implants demonstrate antibac-
terial attachment effects in an in vivo study? (2) Do iodine-




The implants used in the in vivo antibacterial study were
Kirschner wires (K-wire) with a length of 20 mm and a diam-
eter of 1.25 mm. The implants used in the in vitro biofilm
study were metallic washers with a diameter of 6 mm and a
thickness of 0.5 mm. The implants were solid, smooth, Ti-
6Al-4 V titanium implants (Ti), either untreated, treated with
oxide film on the Ti surface by anodization (Ti-O), or treated
with an iodine coating on oxidation film (Ti-I). The iodine
supports were produced at the Chiba Institute of Technology
(Narashino, Chiba, Japan) using a technique described by
Hashimoto et al. [18]. The anodic oxide film shows a thick-
ness of 5–10 μm with more than 50,000 pores/mm2, and the
capacity to support 10–12 μg/cm2 iodine. As for the surface
area, microscopic observations showed that the surface area of
Ti-O and Ti-I clearly increased more than the surface area of
Ti; there was no change between Ti-O and Ti-I (Fig. 1a–c). All
implants were processed by Promedical Instruments
Company (Kanazawa, Ishikawa, Japan).
In vivo analysis of antimicrobial attachment effect
The strain of bacteria used in this study was Gram-positive
Staphylococcus aureus strain ATCC 25923. The bacteria were
incubated in 5 ml of fresh brain-heart infusion (BHI, Bacto™,
Becton Dickinson) in a shaking incubator for 24 h at 37 °C.
The culture was subjected to 10-fold serial dilution with phos-
phate buffered saline (PBS) to finally get to about 5 × 104
colony forming unit (CFU) /ml.
Eighteen male, ten-week-old Sprague-Dawley rats (Japan
Charles River, Japan) weighing 300–350 g were used in this
study. This animal procedure was performedwith the approval
of the animal ethics committee at our institution (approval
date: 3 September 2013; approval number: 132,928). This
in vivo study followed the method outlined in a previous re-
port with slight modifications [19]. The operation was per-
formed under general anaesthesia injected intraperitoneally
with pentobarbital (0.3 mg/kg body weight). The operation
field (bilateral knee joint) was shaved and disinfected with
povidone-iodine. A medial parapatella approach was made
over the bilateral knee joint. We accessed the knee joint, and
a hole was hand-drilled with an 18-gauge needle through the
centre of the knee. Next, 10 μl of PBS containing S. aureus
(almost 5 × 102 CFU) was inoculated into the distal femoral
canal. After bacterial inoculation, the implant was press-fit
into the canal. In this study, we randomly inserted either Ti,
Ti-O, or Ti-I in both knee joints. Finally, skin, fascia, and joint
capsule were closed using 4–0 nylon.
The S. aureus infected rats used in the experiments were
euthanised at 24, 48 and 72 hours post-operatively by intraperi-
toneal injection with pentobarbital (9 mg/kg body weight). All
inserted K-wires were removed under sterile conditions and
placed in 1.5 ml microtubes containing 1 ml PBS. The tubes
were subjected to rapid vortex mixing for one minute to detach
adhered bacteria on the implant surface. The solution was seri-
ally diluted 10-fold with PBS and the final bacterial suspensions
were plated on BHI agar plates for 24 hours at 37 °C. The
number of viable cells was counted for the three types of
implants.
Biofilm formation assay
The biofilm study in vitro was performed as described in the
past report, with a slight modification from Braem et al. [20].
The implant was exposed to Gram-positive Staphylococcus
aureus strain ATCC 25923 which is known to have a tendency
to form biofilm [21]. The bacteria were incubated in 5 ml of
fresh Tryptic Soy Broth [TSB, Bacto™, Becton Dickinson]
with aeration at 37 °C for 24 hours. This culture was diluted
100-fold in TSBwith 1% glucose (wt./vol) and re-incubated at
37 °C for 75 minutes. The re-incubating medium
corresponded to the early exponential growth phase and was
adjusted to obtain an OD600 = 0.2–0.3, giving a bacterial
suspension of 1–5 × 107 CFU/ml. The metal washers were
sterilized in an autoclave and placed into 24-well plates, and
1 ml of the bacterial suspension was added to each well. The
material was statically incubated for 24 hours at 37 °C to allow
bacterial adhesion to the metal surface. After initial bacterial
adhesion, the medium was replaced with fresh TSB medium
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every 24 hours to form a mature biofilm and remove plank-
tonic cells under sterile conditions. Finally, further incubation
was performed under the same conditions for 24 hours and
72 hours after bacterial attachment.
The biofilm formed at 24 hours after bacterial attachment was
studied with fluorescence microscopy, scanning electron micros-
copy (SEM), and the spread-plate method assay. The biofilm at
72 hours after bacteria attachment was studied with the spread-
plate method to investigate biofilm growth for each type of im-
plant. In this study, we used 57 wells (nine wells used in SEM
analysis, 12 wells used in fluorescence microscopy analysis, and
36 wells in quantitative analysis by the spread plate method).
Observation of biofilm by fluorescence microscopy
All washers were gently rinsed in ultrapure water to remove
planktonic bacteria, and the biofilms that had formed on the
metal surfaces were stained using FilmTracer™FM® 1–43
green biofilm cell stain (Invitrogen Life Science), basically
according to the manufacturer’s protocol [22]. In this study,
100 μl of the staining solution was applied to the material
surface; the metal washers were then incubated for 45 minutes
in the dark with a slight modification according to Nganga
et al. [11]. The stained metal washers were rinsed with sterile
ultrapure water to remove excess stain. They were investigat-
ed by using BIOREVO BZ-9000 fluorescence microscopy
(Keyence, Tokyo, Japan). The lens magnification was
20 × (four replicates). The color photographs were converted
to gray-scale images with Adobe Photoshop Elements 12.0
(Adobe Systems, San Jose, CA, USA), and biofilm coverage
rate (BCR) was measured with Image J to calculate the per-
centage of surface covered by biofilm, with a slight modifica-
tion according to past reports [23, 24]. The BCR value of eight
areas were averaged for each implant.
Observation of biofilm by SEM
SEM (JSM 5400; JEOL Ltd) was used to analyze the mor-
phology and distribution of the biofilm formed on the surface.
After PBS washing to remove planktonic cells, the biofilm on
each washer was fixed by immersion in 2.5% glutaraldehyde
at room temperature for 24 hours, and then rinsed with deion-
ized water. For dehydration, the metal washers were passed
through an ascending series of ethanol solutions (50 - 75 - 95 -
100%) for ten minutes at each interval with a final pass
through t-butyl alcohol. Then the washers were dried using a
freeze-dryer. Finally, the biofilm was sputter-coated with plat-
inum palladium using an ion-sputtering system. The fixed
washers were attached to metal folders and viewed with an
SEM at an accelerating voltage of 20 kV and × 2000 magni-
fication (three replicates).
Quantitative analysis of biofilm formation assay
by the spread plate method
We used the spread plate method to conduct a quantitative
analysis of biofilm formation. The washers were gently rinsed
by dipping in PBS to remove non-adherent cells on the sur-
face. Next, they were placed into 1 ml PBS in 1.5 ml
microtubes. The solution was subjected to rapid vortexmixing
for 15 seconds and then sonicated for five minutes (Bransonic
Branson 5210, Kanagawa, Japan) at a frequency of 40 Hz to
disrupt the formed biofilm. Finally, rapid vortex mixing of the
solution was performed again for one minute. This method of
disrupting the biofilm was performed with a slight modifica-
tion according to Braem et al. [20]. Quantitative analysis was
done using the standard plate count method. The solution
containing bacteria derived from the biofilm was subjected
to ten-fold serial dilution using PBS, and the bacterial suspen-
sions were plated on TSB agar plates for 24 hours at 37 °C.
The number of colonies was counted on all plates. This study
was repeated six times.
Statistical analysis
Statistical analysis was performed using SPSS software
(PASW Statistics Base version 19; SPSS, Chicago, Illinois).
Antimicrobial attachment effect, BCR, and quantitative
Fig. 1 Electronmicroscopic evaluation ofmetal implant surfaces: titanium implant (a), Ti-O implant (b), Ti-I implant (c). Original magnification × 2000
(scale bar = 5 μm)
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biofilm formation analysis by the spread plate method were
compared between groups by Mann-Whitney U test. A p-val-
ue < 0.05 was considered statistically significant.
Results
1) Do iodine-supported implants demonstrate antibacterial
attachment effects in an in vivo study?
All rats were alive and all implants were explanted under
sterile conditions. Mean viable bacterial numbers in Ti, Ti-O,
and Ti-I were 5.6 ± 2.1 × 103 CFU, 8.4 ± 2.4 × 103 CFU, and
1.2 ± 0.7 × 103 CFU at 24 h (Fig. 2a); 6.4 ± 2.1 × 104 CFU,
7.9 ± 2.3 × 104 CFU, and 8.6 ± 2.6 × 103 CFU at 48 h (Fig. 2b);
and 2.0 ± 0.6 × 105 CFU, 2.9 ± 0.6 × 105 CFU, and
5.0 ± 2.1 × 104 CFU at 72 h (Fig. 2c). Themean viable bacterial
number was significantly lower on Ti-I2 than on Ti or Ti-O2
implants; there was no significant difference between the mean
viable bacterial numbers on the Ti and Ti-O implants.
2) Do iodine-supported implants inhibit biofilm formation
and growth in an in vitro study?
In fluorescence microscopy images, biofilms were ob-
served on all surfaces and were stained green by using
FilmTracer™FM® 1–43 green biofilm cell stain (Fig. 3).
BCR in Ti, Ti-O, and Ti-I were 11.4 ± 2.4%, 39.6 ± 3.4%,
and 3.1 ± 1.0%. This result demonstrated that a wide area was
covered by the stained biofilm on the surface of Ti and Ti-O
compared with the surface of Ti-I (Fig. 4). This tendency was
observed across the entire surface of all three metals.
The biofilm formation observed in SEM images as the
mass of the microcolonies confirmed this difference in biofilm
morphology or distribution. The biofilm formation was also
observed on all surfaces in fluorescence microscopy images.
In particular, these images showed that the bacteria on Ti and
Ti-O was accumulated and more tightly colonized than for Ti-
I. The bacterial slime formed on Ti or Ti-O clearly included
many microcolonies compared with Ti-I although bacterial
colonization could be seen on all implants (Fig. 5).
Viable bacteria within the biofilm tended to increase over
time on all metal surfaces using the spread plate method. At
Fig. 3 Biofilm formation in fluorescence microscopy images. a Titanium implant. b Ti-O implant. c Ti-I implant. Original magnification × 20 (scale
bar = 100 μm)
Fig. 2 Antimicrobial attachment test results (n = 4). a 24 hours after
inoculation. b 48 hours after inoculation. c 72 hours after inoculation.
Data are expressed as mean ± standard deviation.※ p<0.05
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24 hours or 72 hours after bacterial attachment, there was a
significant difference in the number of viable bacteria between
Ti-I and Ti or Ti-O (Fig. 6a, b). On the other hand, there was
no significant difference between Ti and Ti-O in the amount of
viable bacteria within biofilms.
Discussion
Inhibition of biofilm formation on iodine-supported implants
is very effective in preventing early post-operative implant
related infection. Povidone-iodine, the coating material used
in this study, is a broad-spectrum antimicrobial agent frequent-
ly used in orthopaedic surgery. The antibacterial spectrum of
iodine includes not only general bacteria including
staphylococcus, but also viruses, tubercle bacilli, and fungi
[25]. Furthermore, it has low potency for developing resis-
tance and adverse reactions because iodine is a trace metal
and an essential component of the thyroid hormone [26]. We
would expect iodine-supported implants to have good antibac-
terial effects and low toxic effects on human cells in compar-
ison to silver.
Our study had several limitations. First, there was no long-
term investigation of the antimicrobial attachment effect or the
inhibition of biofilm formation on iodine-supported implants.
However, the postoperative surgical site infection was
established by attaching the metal surface firstly in the acute
phase, and therefore showed that the iodine-supported im-
plants were very effective in preventing initial microbial at-
tachment. Further study would be needed to assess the long-
Fig. 5 Biofilm formation in scanning electron microscopy images. a Titanium implant. b Ti-O implant. c Ti-I implant. Original magnification × 2000
(scale bar = 5 μm)
Fig. 4 Biofilm coverage ratio. a Titanium implant. b Ti-O implant. c Ti-I
implant. Data are expressed as mean ± standard deviation.※ p<0.05
Fig. 6 Quantitative biofilm formation analysis by the spread plate
method (n = 6). a 24 hours incubation after bacterial adhesion. b
72 hours incubation after bacterial adhesion. Data are expressed as
mean ± standard deviation.※ p<0.05
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term effects. Secondly, in this study, the implants were ex-
posed to only methicillin-sensitive Staphylococcus aureus
(MSSA). The antimicrobial attachment effect of methicillin-
resistant Staphylococcus aureus (MRSA) or Pseudomonas
aeruginosa, which are well known to form biofilms on metal
surfaces, also should be evaluated in the future. Finally, we did
not investigate the chronological influence of iodine release in
basic research. Further study would be also needed.
The results of our study in vivo indicate that iodine-
supported implants have strong antimicrobial attachment ef-
fects. Shirai et al. reported that iodine-supported implants have
favourable antimicrobial attachment properties in vitro, and
our results in vivo were consistent with this report [17].
However, the mean viable bacterial number on Ti-O surfaces
tended to increase compared with Ti implants, although there
was no statistical difference in the mean viable bacterial num-
ber between Ti and Ti-O. Several previous reports showed that
surface area is related to bacterial attachment [27, 28]. Ti im-
plants were anodized to support the iodine on the Ti implant
surface, and apparently the anodization resulted in an in-
creased surface area (Fig. 1a–c). Necula et al. reported that
Ti implants anodized to support Ag and increase the surface
area of implants resulted in the complete killing of methicillin-
resistant Staphylococcus aureus, whereas many viable bacte-
ria were recorded on the Ti or Ti-O implants in our in vitro
study [29]. Because Ti-I was impregnated with povidone-
iodine more widely due to the increased surface area, the con-
tact area between the povidone-iodine and bacteria was in-
creased, so rather than increasing the bacterial attachment,
Ti-I could obtain good antimicrobial attachment effects com-
pared with Ti and Ti-O.
In fluorescence microscopy images and SEM images, our
results showed the bacteria on Ti and Ti-O was accumulated
and more tightly colonized than for Ti-I (Figs. 3, 4, and 5).
Furthermore, our quantitative biofilm analysis by the spread
plate method found a significant difference in the number of
viable bacteria between Ti-I and Ti or Ti-O at 24 h or 72 h after
bacterial attachment (Fig. 6a–b). Consequently, we can con-
clude that Ti-I has a stronger anti-biofilm effect than Ti or Ti-
O. Past reports showed that biofilm formation is related to the
initial bacterial attachment on a metal surface [30, 31].
Therefore, our in vivo results showing the antimicrobial at-
tachment effect on Ti-I were associated with inhibiting biofilm
formation on the metal surface. There was significant differ-
ence between BCR on the Ti and Ti-O implants. Because the
Ti-O surface area tended to increase compared with Ti im-
plants, a wide area was covered by the stained biofilm on
the surface of Ti-O compared with the surface of Ti [27, 28].
Microscopic analysis showed a clearer difference than the
spread plate method. This is because with the spread plate
method, sonicating the biofilm on the metal surface may ex-
cessively destroy viable bacteria. Even considering this possi-
bility, the in vivo and vitro results showed that the iodine-
supported implant inhibits biofilm formation by preventing
initial bacterial attachment on the metal surface. Clinically,
we believe that iodine-supported implants may have the po-
tential to prevent, or at least dramatically reduce, postopera-
tive implant related infection.
Conclusions
This study showed that iodine-supported implants have a
good antibacterial attachment effect in vivo and inhibit biofilm
formation and growth. Our results indicate that iodine-
supported implants may have great potential as innovative
antibacterial implants that can prevent implant related infec-
tion in orthopaedic surgery.
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